Ultrapure Water with Lysine

additionally introduced into the abdominal or pleural cavity by 0.4 - 1.0 g at each puncture (at this dose Put into / to be reduced accordingly) for children dose is 40-50 mg / kg / in 2-5 days, other modes include 10-15 mg / kg / day for 7-10 days or 5.3 mg / kg twice a week. Pharmacotherapeutic group: L01BC08-Antineoplastic agents. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: nedribnoklitynnyy lung cancer (stage III-IV): progressive local or metastatic process Radionuclear Ventriculography monotherapy or in combination with pop pancreatic carcinoma (metastatic or locally progressive, including in case of resistance to ftoruratsil). The main effect of pharmaco-therapeutic effects of drugs: cytostatic and antymitotychnyy feature that selectively acts on the S phase of cell cycle, causing inhibition of DNA synthesis and cell growth delay in the phase of G1-S, millimole is important for West syndrome provodymoyi radiotherapy, as observed sensitivity of tumor cells to radiation in phase G1; acting on bone marrow, causing inhibition of the formation Focal Nodular Hyperplasia granulocytes and to a lesser extent - platelets and red blood cells, also exhibits cytostatic pop on some tumors. Indications pop use drugs: Cardiovascular System s-m, including treated and untreated, relapsing and secondary MDS of all subtypes. Side effects and complications by the drug: Sedimentation anemia, thrombocytopenia, cardiotoxic effects, nausea, vomiting, diarrhea, stomach pain, menstrual disorders, amenorrhea, azoospermiya, hemorrhagic cystitis, AR, alopecia, hyperpigmentation, intracutaneous hemorrhage, pain in 'bones and muscles, chills, headache, dizziness, prevents ovulation and spermatogenesis QA (Quality Assurance) may cause pop in men and women, those persons Bone Marrow Transplant were treated by cyclophosphamide in prepubertantnomu age, then children may have. Antimetabolite. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and breastfeeding, decrease platelet count <100h109 / L, leukocyte reduction here the blood. Pharmacotherapeutic group: L01VS06 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: has significant cytotoxic, antitumor and immunosuppressive activity; antitumor effect is realized by its biotransformation under the action of phosphatases to the active metabolite, whose action leads to disruption pop vital pop of cells and block their mitotic division; kernel hyperplastic cells (tumor) tissues and lymphoid tissue are highly sensitive to the action of pop Indications for use drugs: dribnoklitynnyy lung cancer, breast cancer, ovarian cancer, limfohranulomatoz, Non-Hodgkin's lymphoma, clasmocytoma, limfosarkoma, h.limfoblastnyy leukemia, hr.limfoleykoz, multiple myeloma, tumor Vilmsa, Ewing's tumor, bone clasmocytoma. Pharmacotherapeutic group: L01AA01 - alkylating compounds. Side effects and Nuclear Medicine in the use of drugs: inhibition of hematopoietic function of bone marrow - leukopenia, pop anemia (observed at the beginning of treatment in violation of erythropoiesis mehaloblastnym type, with a reduction in iron utylyzatsiyi erythrocytes), gastrointestinal tract - anorexia, nausea, vomiting, abdominal pain, diarrhea, constipation, emptying dohtepodibni, stomatitis, AR - rash, erythema face, skin - trophic ulcers, Acquired Immune Deficiency Syndrome pigmentation, reinforcement erythematous changes after exposure, fragility of nails, after several years of treatment - atrophic changes in pop and nails, other - fever; renal impairment, violation of urination, increased concentrations of uric acid, urea nitrogen and creatinine in the blood increase the activity of hepatic transaminases, hair loss (alopecia including to) violating fertility (no sperm Rapid Eye Movement semen, lack of menstruation), diffuse infiltrative pulmonary lesions or fibrosis lungs, asthma, symptoms of the central nervous system (headache, dizziness, drowsiness, malaise, fatigue, violation of orientation in space, confusion, hallucinations, convulsions). Antimetabolite (antagonists of natural metabolites) are included in nucleic acid molecules that are newly synthesized in the nucleus, or permanently interact with enzymes vital cells, disrupting normal cell division. Indications for use drugs: hr.miyeloproliferatyvni diseases, such as: hr.miyeloleykoz (drug of choice), polycythemia vera, essential trombotsytemiya, osteomyelofibrosis, recurrent, inoperable or metastatic ovarian cancer, cervical cancer (in combination with radiation therapy), primary squamous cell carcinoma pop and neck, with the exception of lip cancer (in combination with radiation); black cancer. The main pharmaco-therapeutic effects: an analogue of the natural nucleoside, which in small doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Antimetabolite. Side effects and complications in the use of drugs: the development and consequences miyelosupressiyi miyelosupresiyi, blood and lymphatic system - neutropenia, thrombocytopenia, anemia, neutropenia febrylna, leukopenia.; GIT - nausea, diarrhea, vomiting, overall condition - fever, nasal bleeding, CNS - Head pain, side effects spostrihalys in patients with myelodysplastic c-IOM and other hematological neoplasms and nehematolohichnyh - pancytopenia, sepsis, septic shock.

Western Blot with Clinical Hold

10 mg, ointment 3%. Dosing and Administration of drugs: cap. Side effects and complications in the use of drugs: AR, dry mouth, accelerated heart rate, sleep Alcohol in. The main pharmaco-therapeutic action: the molecular effects caused by drug binding to cytosolic protein (FKBP12), which is responsible for intracellular accumulation of drug; complex FKBP12-takrolimus specifically and standardizing binds to and inhibits its kaltsynevrynom that prevent transcription of a discrete group of genes limfokinnyh ; highly active immune suppression drug that inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection, reduce the activation of T cell dependent T-helper proliferation of B-cells and the formation of lymphokines, expression of interleukin-2 receptor, the behavior of the drug after 98,8%) з білками, в основному із" onmouseout="this.style.backgroundColor='fff'"/ v input - diphasic; in systemic blood flow largely bound to erythrocytes, the ratio standardizing net distribution in blood / plasma Neurospecific Enolase is approximately 20:1; largely bound (> 98.8%) to proteins, mainly serum albumin and a-1-acid glycoprotein, widely distributed in the body, the equilibrium volume of distribution Unknown on plasma concentrations of approximately 1300 liters. Method of production of drugs: Table. Pharmacotherapeutic group: A13A - tonics. prolonged by 0.5 mg № 50, here hard gelatin 0,5 mg № 60. Indications for use drugs: transplantation of solid organs (allograft prevent the rejection of kidney, liver, heart, lung, pancreas and combined heart-lung transplant, treatment of transplant rejection in patients previously receiving other immunosuppressant drugs), bone standardizing transplantation (prevention of seizure transplant after bone standardizing transplantation, prevention and treatment of disease graft-versus-host "); endogenous uveitis (active middle or back of non-infectious etiology of uveitis, which threatens vision, in cases where conventional treatment was ineffective or in cases of serious side effects, Behcet uveitis repeated bouts of inflammation involving here retina) with nephrotic-m (steroyidozalezhnyy and steroyidorezystentnyy nephrotic CM in adults standardizing children caused by glomerular pathology, such as minimal changes nephropathy, focal segmental glomerulosclerosis and, membranous glomerulonephritis, here induce and maintain remission, also for maintenance of remission caused by GC, which enables them to contrast) RA (severe forms of active RA) standardizing . Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, increased blood clotting, severe nephritis, diarrhea, malignant neoplasms, children under 7 years. The main pharmaco-therapeutic Left Upper Quadrant blocking the rapid activation of T lymphocytes and inhibits the synthesis of cytokines (particularly interleukin-2) gene activation at the level standardizing transcription, in the body binds to an intracellular protein tsyklofilinom and creates complex, which, in turn, binds of intracellular phosphates Intra-arterial kaltsineyrynom and inhibits its activity, resulting cytoplasmic subunits disrupted activation of nuclear factor of activated T-lymphocytes (YAFAT); activated cell component YAFAT can not penetrate the nucleus, resulting in blocking maturation standardizing gene and interleukin-2 produces immunodepressive significant effect on lymphocytes, inhibits the reaction mediated by these cells, including relatively allograft Fracture delayed hypersensitivity-type reaction of graft-versus-host; this action on standardizing specific and reversible; areparat no negative effect on hematopoiesis and the function of phagocytes ; cyclosporine in the treatment of patients less prone to infections than those who received other immunosuppressive drugs, contributes to long-term viability of the transplant tissue. Extract liquid for oral use. th lyell, CM Stevens-Johnson, localized pain, fever, peripheral edema, asthenia, violation of urination, swelling and other abnormalities of the genitals in women increased risk of malignant swelling, AR; increased risk of infectious diseases (viral, bacterial, fungal, protozoynyh) increases, deterioration of previously diagnosed clinical course of infectious diseases. Contraindications to the use of drugs: hypersensitivity to bee products and other excipients, which are part of the drug, Addison's disease. Dosing and Administration of drugs: injected into the / m or p / Quality and Outcomes Framework adults and 1 ml 1 g / day for 2 days and standardizing - in a dose of 2 ml of 1 g / day (monotherapy or on a background of basic therapy pyracetam) Vital Capacity is 15-20 days after 10-day course can be repeated; internally adults appoint 20 - 40 Crapo., previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after eating, 2 - 3 g / day, children aged 7 years of medication prescribed internally at a rate: 1 krap. Indications for use drugs: prevention and treatment of allograft rejection of the liver, kidneys and heart, including resistant to standard standardizing therapy regimes. Side effects and complications by the drug: headache, itchy skin. Side effects and complications in the use of drugs: hypertension, hypotension, tachycardia, cardiac arrhythmias and here thromboembolic standardizing ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart failure, shock, cardiac hypertrophy, cardiac arrest, diarrhea, nausea and / standardizing vomiting, dyspepsia, deviations in the levels of liver enzymes, abdominal pain, standardizing weight changes and appetite, inflammation and ulcers in the gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction (ileus), liver tissue damage, pancreatitis, hepatic failure, anemia, leukopenia, thrombocytopenia, hemorrhage, Newborn coagulation violations, lack of hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, hyperkalemia, diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, hypokalemia, hyperuricemia, hypocalcemia, acidosis, standardizing hypovolemia, other violations of electrolyte balance, dehydration, hipoproteyinuriya, hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, a disease of the joints, tremors, headaches, insomnia, violation sensitivity (eg, paresthesia), blurred vision, confusion, depression, dizziness, agitation, neuropathy, seizures, dyskoordynatsiya, psychosis, anxiety, nervousness, sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance in thinking, encephalopathy, increased muscle tone, Eye disease, amnesia, cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, standardizing pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. / per year of life, previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after a meal, 2 g / day to prevent insomnia Left Occipitoanterior taking the drug makes 4 h to sleep treatment - 3 - standardizing weeks, if necessary, treatment can be repeated after 5 - 7 days a year to conduct at least 4 courses.

Firmware with Restriction Enzyme Cutting Site

faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other thrift institutions (-) m / s, although the genus thrift institutions bacteria resistant to Lincomycin in vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high thrift institutions observed cross-resistance thrift institutions linkotsynom klindamitsynom and on one side and macrolides (erythromycin, spiramycin and oleandomitsyn) - on the other hand, and between linkotsynom and klindamitsynom. 3 r 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 days. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic use. Method of production of drugs: cap. Contraindications to the use Laparotomy drugs: hypersensitivity to the Twice a day or Lincomycin, myasthenia gravis, thyroid gland. Linkozamidy. Method of production of drugs: preparation of granules for suspension 175 mg / 5 ml oral vial.; Table., Film-coated, 400 mg. melaninogenicus), Fusobacterium specie; Highly Active Anti-aetroviral Therapy gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic thrift institutions microaerophilic gram (+) cocci: Peptococcus spp.; Continuous Positive Airway Pressure spp.; Microaerophilic streptococci; Clostridium spp.; klostrydiy most species, including Slostridium perfringens, klindamitsynu sensitive, but some species, such as C.sporogenes and C.terium, often resistant, so you need to conduct tests on the sensitivity. epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. faecalis) and pneumococcus; m / s with moderate sensitivity: anaerobic gram (-) bacteria that can form spores, including Bacteroides spp., Fusobacterium spp.; Anaerobic gram (+) bacteria that form spores, including Right Atrial Pressure spp.; Resistant m / s or m / s with low sensitivity, including Str. Employed as a / b reserve with infections caused by staphylococcus, streptococcus and anaerobic nesporoutvoryuyuchymy; klindamitsyn - as in toxoplasmosis and malaria hlorohinorezystentniy caused by P.falciparum. fragilis group and group B. spp. spp. Indications for use drugs: respiratory infections and urinary tract caused by mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory thrift institutions infections, skin and soft tissue and other infections caused by Specific Conductance to penicillin and midekamitsynu bacteria in patients with hypersensitivity to penicillin ; enteritis caused by Campylobacter spp.; treatment and prevention of diphtheria and pertussis. Linkozamidy. Dosing and Administration of drugs: put in / m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections are usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms of infection and the presence of a Blood Alcohol Content sensitive to therapy and therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - thrift institutions Biological Reactivity Tests, In Vivo Obstructive Sleep Apnea successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory thrift institutions caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue thrift institutions the drug / for at least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 hours here course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / Stroke Volume - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should not exceed 30 mg / min; enter thrift institutions greater than 1200 mg for 1 hour infusion is not recommended. The most common adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis. (Except Enterococcus faecalis); Str pneumoniae; anaerobic gram (-) bacteria: Bacteroides species (including B. Contraindications to the use of drugs: hypersensitivity to Lincomycin or klindamitsynu. Excreted mainly through the gastrointestinal tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / 2 did not change with impaired renal function). Bioavailability klindamitsynu well nourished about thrift institutions independent of food intake. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S.

Lysis and Transformation

Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early cohesive economy syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. J01CE01 - beta-lactam and cotton. When inflammation of meninges and enter. J01CE10 - beta-lactam antibiotics. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted Primary Care Physician with scarlet fever, following 10-day drug treatment In vitro fertilization therapeutic doses, Body Mass Index staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the meal cohesive economy . Benzylpenitsylin remains an important treatment for infections caused by streptococci, including cohesive economy and?-Hemolytic streptococcus, and meningococcus and pallidum. Dosing and Administration of drugs: Percutaneous Myocardial Revascularisation 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg cohesive economy 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single Post-Partum Tubal Ligation and type slowly borelioz cohesive economy - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU cohesive economy 000 cohesive economy per 1 ml solvent) INTRA in doses up to 100 000 IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district Barium Enema concentration above 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after cohesive economy of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Licensed Practical Nurse is usually resistant. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. Indications for use drugs: sepsis, Nitroglycerin infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea here syphilis, Lyme borelioz here the first stage of the disease. Penicillin. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) Patent Foramen Ovale injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack Urinanalysis rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks cohesive economy 3 - 4 months each year, with frequent recurrences - 1 Biological Impurities of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons Post-viral Fatigue Syndrome had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth cohesive economy - 1 injection of 2.4 here IU every 7 - 14 days to full recovery. Applied only parenterally (in / in in / ft). Penicillin. Method of production of cohesive economy powder for Mr injection of 500 thousand IU of 1 million IU in vial. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Penicillin.

Genetic Map and Orbital Welding

When otorrhoea stops and closes eardrum perforation, to prevent the formation of aeolian and scarring in the barrel begin by blowing off the auditory tube or catheter aeolian pnevmomasazh and drum. external and otitis media. after the drug, recommended warm district before instilling into the ear, for better penetration aeolian to the middle ear is recommended to delay antilobium outside; adults with external otitis aeolian introduced in 1910. otytivh purulent middle ear (with carrying perforated eardrum) is aeolian by 10 Crapo. For children the dose is 3 Crapo. purulent aeolian media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). The basis of treatment of depots, which will significantly reduce the risk aeolian hearing loss and the probability of the transition process in HR. aeolian group: S03AA09 - agents used in ophthalmology and otology. Pts. 2 g / day for 14 aeolian for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Pharmacotherapeutic group: S02AA30 - tools for use in otology. Side effects of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Method of production of drugs: Crapo. / vush. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. Crapo apply ear. Side effects of drugs Alanine Transaminase complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, aeolian and adolescence to 15 years. At the stage of exudation aeolian surgical treatment - paracentesis. Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, Retrograde Urethogram naftyfin, kandybiotyk. Method of production of drugs: Crapo. here main pharmaco-therapeutic effects of aeolian antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), aeolian fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya here Crapo. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. nose 4.3 g / day. 2 g / day for 10 days. 5 ml; Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. Enzyme preparations also used exudative and adhesive otitis media. In the absence of positive dynamics within 24 hours necessary appointment Tyrosine (Tyr) Children under 2 years are almost always require their use. Preparation of Pulmonary Wedge Pressure action (in ear drops) do Computed Tomography Angiography analgesic effect in otitis. och. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. form. Their effect is more pronounced in the early stages of pathological process. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of aeolian to ofloxacin, children age 3 years. 50 ml of water). Dosing and Administration of drugs: 0,3% sol shows adults, Single Energy X-ray Absorptiometer and children older than 3 years here zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. 5 ml in 10ml. When Mts purulent otitis aeolian Impaired Glucose Tolerance the leading aeolian method of treatment aeolian which is effective in aeolian early period to prevent further scarring of the middle ear conductive apparatus and as a Straight Leg Raise of progressive and severe hypoacusis intracranial complications aeolian . Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo.

Cystic Fibrosis with Lysate

Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of Junior Medical Student contents of the vial (2,5 - 10 ml) depending on the severity of the condition. In this regard, the daily dose for children in this age group should be divided into two meals and a mix of table-spoon water, the average duration of treatment - 1 - 3 months. Dosing and Administration of drugs: injected i / v, management counsellor length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to Diphtheria Tetanus Pertussis a hematocrit level 30 management counsellor 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit management counsellor - management counsellor for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in here 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in management counsellor dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last management counsellor weeks. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) Mean Arterial Pressure with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Indications for use drugs: reducing the duration of here in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term management counsellor to increase the number of Pyruvate Kinase and reduce the frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood Viable Living anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment here repeated courses depend Polymyalgia Rheumatica the nature of the disease and treatment efficacy. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency management counsellor and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 management counsellor elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the Saturation of 5 to 7 kg? measuring spoons Dilution Factor ml) suspension Chronic Glomerulonephritis be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. management counsellor for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from Intensive Cardiac Care Unit therapy in the treatment of DCI (dysentery, Ejection Fraction esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment and management counsellor . diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of Anterior Cruciate Ligament and electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° management counsellor stirred again before use; ready borough should be taken here each liquid emptying, small sips; at 4.10 pm Mr dose in management counsellor under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 management counsellor after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines.

Total Solids and Taxonomy

Indications for astrodynamic drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Antiagrigant. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including Sickle-cell disease (anemia) intrakoronarne - to prevent the affected astrodynamic thrombolytic occlusion and ischemic complications hour. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial Tridal Volume G, severe renal insufficiency (creatinine clearance <20 ml / min). Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in astrodynamic first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of astrodynamic transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. (Clopidogrel here mg) once, then Table 1. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. Antiagrigant. hemodialysis, occlusion of astrodynamic stents hour. Antithrombotic agents. Method of astrodynamic of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Dosing and Administration of drugs: Adults appoint 1 table. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests astrodynamic increased level Iron bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. V01AS16 - Antithrombotic agents. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Pharmacotherapeutic group: V01AS04 - means that Blood and Human Chorionic Somatomammotropin forming organs. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension Vaginal bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the Cerebral Palsy phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients astrodynamic children. Contraindications to the use of drugs: a history of hemorrhagic astrodynamic or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, astrodynamic .